DexCom Holds A VGM Score and Growth Score Forecasting 19.1% Fiscal 2026 Growth
DexCom currently holds a #3 rating with an A VGM Score and an A Growth Score forecasting 19.1% year-over-year earnings growth for fiscal 2026. Seven analysts raised earnings estimates by $0.02 to $2.49 per share and DexCom has delivered an average earnings surprise of +3.8%.
1. Current Rating and Style Scores
DexCom holds a #3 rating with A VGM and A Growth Scores, combining value, growth and momentum metrics to guide investing decisions.
2. Analyst Estimate Revisions
Seven analysts revised fiscal 2026 EPS forecasts upward by $0.02 to $2.49 per share, reflecting improved projections for revenue growth and margins.
3. Earnings Surprise Performance
Over recent quarters, DexCom has outperformed estimates by an average of +3.8%, underscoring consistent operational execution.